Immuneering Corporation
IMRX
$1.45
-$0.01-0.69%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -19.68% | -15.90% | -15.52% | -5.17% | -13.88% |
| Total Depreciation and Amortization | -3.81% | 12.50% | 14.25% | 16.35% | -83.92% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 32.25% | 32.05% | 30.44% | 17.63% | 216.47% |
| Change in Net Operating Assets | -10.19% | 17.25% | 2,573.43% | -28.38% | 297.66% |
| Cash from Operations | -23.23% | -12.02% | -7.23% | -7.44% | -0.23% |
| Capital Expenditure | 94.50% | 90.72% | 62.17% | -33.93% | -146.61% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 66.47% | 77.38% | -45.95% | 12.79% | -59.82% |
| Cash from Investing | 75.26% | 77.41% | -45.79% | 12.76% | -61.57% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,007.69% | 20,295.33% | -100.00% | 309.31% | -81.47% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | -625.64% | 20,295.33% | -100.00% | 309.31% | 104.22% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.94% | 59.63% | -124.67% | 43.56% | -128.36% |